Open AccessMultiple Sclerosis and Clinical Gait Analysis before and after Fampridine: A Systematic Review
Author(s) -
Magaly Lecat,
Pierre Decavel,
Éloi Magnin,
B. Lucas,
Vincent Grémeaux,
Yoshimasa Sagawa
Publication year - 2017
Publication title -
european neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.573
H-Index - 77
eISSN - 1421-9913
pISSN - 0014-3022
DOI - 10.1159/000480729
Subject(s) - multiple sclerosis , physical medicine and rehabilitation , gait , psychology , medicine , neuroscience , psychiatry
Gait impairment is one of the most disabling symptoms in people with multiple sclerosis (PwMS). Fampridine, has demonstrated a positive effect on gait speed in PwMS after 14 days of treatment but the long-term effects have not yet been demonstrated. This study reviews the long-term effects of fampridine on gait in PwMS.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom